Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Precision Medicine Study Points to Promising New Approach in Alzheimer's
BioSpace
Fri, 05/21/21 - 10:53 am
Tags:
Alzheimer's disease, precision medicine, Eli Lilly
Eli Lilly sues HHS to halt any 340B-related monetary penalties
Endpoints
Fri, 05/21/21 - 10:50 am
Tags:
HHS, 340B, Eli Lilly
Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits
Endpoints
Thu, 05/20/21 - 11:11 am
Tags:
Eli Lilly, diabetes, Trulicity, tirzepatide, clinical trials
FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option
Pharmaforum
Wed, 05/19/21 - 10:26 am
Tags:
Eli Lilly, Innovent, China, sintilimab, Keytruda, Merck, immunotherapy
Feds stop sending Eli Lilly’s COVID-19 cocktail to Illinois on concerns of P.1 variant
Fierce Pharma
Thu, 05/13/21 - 11:56 pm
Tags:
Eli Lilly, COVID-19, Illinois, FDA, antibodies, bamlanivimab
Lilly enlists a long-incubating RNA upstart in new $1.25B partnership
Endpoints
Tue, 05/11/21 - 11:06 am
Tags:
MiNA Therapeutic, RNA, Eli Lilly
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Mon, 05/10/21 - 09:31 pm
Tags:
Joe Biden, Alzheimer's disease, Denali Therapeutics, Cassava Sciences, Eli Lilly
Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib
Fierce Pharma
Mon, 05/10/21 - 09:25 pm
Tags:
Eli Lilly, baricitinib, India, drug manufacturing, COVID-19
An employee complaint at Eli Lilly's Branchburg plant alleges altered quality control docs amid FDA probe — report
Endpoints
Wed, 05/5/21 - 11:06 am
Tags:
Eli Lilly, COVID-19, antibodies, drug manufacturing
Lilly takes variant-busting COVID-19 antibody into the clinic
Fierce Biotech
Tue, 05/4/21 - 10:44 am
Tags:
Eli Lilly, antibodies, COVID-19
Crowded psoriasis market cuts Lilly’s mirikizumab ambitions
Pharmaforum
Wed, 04/28/21 - 10:24 am
Tags:
Eli Lilly, psoriasis, mirikizumab
Lilly, citing FDA feedback, won't seek speedy approval of Alzheimer's drug
BioPharma Dive
Tue, 04/27/21 - 11:25 pm
Tags:
Eli Lilly, Alzheimer's disease, donanemab
Eli Lilly Stock Crumbles As Covid Antibodies Hammer Sales, 2021 Outlook
Investors Business Daily
Tue, 04/27/21 - 10:51 am
Tags:
earnings, Eli Lilly
Lilly scraps IL-23 psoriasis program despite phase 3 success, focuses on IBD race against AbbVie, J&J
Fierce Biotech
Tue, 04/27/21 - 10:50 am
Tags:
Eli Lilly, mirikizumab, psoriasis
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
Tags:
funding, venture funding, venture capital, AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Merck KGaA, Pfizer, Roche, Sanofi, Takeda
Eli Lilly retakes innovation crown, while Bristol Myers rates most inventive pharma in annual study
Fierce Pharma
Thu, 04/22/21 - 11:33 pm
Tags:
Eli Lilly, innovation
Lilly to seek first approval of an autoimmune drug for hair loss
BioPharma Dive
Wed, 04/21/21 - 11:26 pm
Tags:
Eli Lilly, alopecia areata, baricitinib, clinical trials
A new market beckons for Alzheimer’s blood tests
EP Vantage
Mon, 04/19/21 - 11:12 am
Tags:
Alzheimer's disease, diagnostics, donanemab, Eli Lilly, Biogen, Quanterix
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Reuters
Fri, 04/16/21 - 09:48 am
Tags:
Eli Lilly, FDA, antibodies, COVID-19, bamlanivimab
Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab
Endpoints
Thu, 04/15/21 - 10:39 am
Tags:
Eli Lilly, Dermira, Qbexza, layoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.